Digital health has the potential to fuel new relationships, insights and trust between pharma companies, patients and providers by creating new insights and value for individuals as well as enhancing population health management.
For pharma, digital tools represent a new avenue for reaching and understanding the patients they serve, creating opportunities for targeted, high-value product development and post-marketing programs. In this opening panel discussion, speakers will discuss current state of pharma-payer-provider collaborations, strategies and opportunities.
Key Takeaways • What are the opportunities for all stakeholders, including patients? • How will health IT will help drive this new business model? • How can all stakeholders work together to improve patient access, experience and outcomes?